Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaad.2017.01.024 | DOI Listing |
Neurourol Urodyn
November 2024
Department of Urology, Stanford University, Stanford, California, USA.
J Urol
November 2024
Department of Urology, Oregon Health & Science University, Portland, Oregon.
Purpose: Urologic surgery involving placement of an indwelling ureteral and/or urethral drain can be associated with significant catheter-related bladder discomfort causing increased postoperative morbidity and opioid medication use. We sought to assess if a single dose of oxybutynin given preoperatively reduces immediate postoperative opioid use in common pediatric urology surgeries.
Materials And Methods: This single-institution retrospective study identified pediatric patients who underwent surgery on the urinary tract with concomitant placement of a urethral and/or ureteral drain.
J Spinal Cord Med
July 2024
Department of Physical Medicine and Rehabilitation, Mahatma Gandhi Medical College and Hospitals, Jaipur, Rajasthan, India.
Study Design: This study is a randomized, investigator-blinded, controlled trial with a non-inferiority design.
Objective: To investigate the effectiveness of neuromodulation by transcutaneous electrical stimulation of the somatic afferent nerves of the foot in neurogenic detrusor overactivity (NDO) in persons with spinal cord injury (SCI) and compare its effectiveness with oral oxybutynin.
Setting: The study was conducted in a rehabilitation in-patient ward of a tertiary care hospital.
Int J Mol Sci
May 2024
Graduate School of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney, NSW 2052, Australia.
The impact of age on mesenchymal stromal cell (MSC) characteristics has been well researched. However, increased age is concomitant with increased prevalence of polypharmacy. This adjustable factor may have further implications for the functionality of MSCs and the effectiveness of autologous MSC procedures.
View Article and Find Full Text PDFUrologie
July 2024
FARCO-PHARMA GmbH, Gereonsmuehlengasse 1-11, 50670, Köln, Deutschland.
Existing therapies for neurogenic detrusor overactivity (NDO), i.e. oral anticholinergics and botulinum toxin injections, can be associated with serious adverse effects or are not always sufficiently effective.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!